Company Overview:

Otsuka is a global healthcare company driven by our purpose "to defy limitation, so that others can too." Patients are at the center of our purpose as we seek to discover and deliver innovative healthcare solutions. Otsuka is a leader in the CNS therapeutic area (TA), which is comprised of a strong portfolio of individual development and marketed assets. As we continue to develop innovative medicines for those with CNS disorders, we are seeking a skilled and experienced Medical Director of CNS Early Assets, Global Medical Affairs, responsible for certain assets within the broader CNS TA portfolio Medical Affairs (both US and Global), with a specialization in Psychiatry and/or Neurology.

Accountable for a subset of assigned assets within the CNS TA which align to the broader overall TA strategy determined by the Sr. Director, Franchise Lead CNS Early Assets.

Position Summary:

The Medical Director, Global Medical Affairs, CNS Early Assets will be responsible for supporting and executing the strategic vision for a select group of assigned assets within our CNS TA (encompassing Psychiatry and emerging Neurology portfolio). This role will report to the Sr. Director, Global Medical Affairs, Franchise Lead CNS Early Assets.

Assets under this person's responsibilities may include treatments for several serious illnesses with unmet needs in various stages of early development. This role will involve collaborating with cross-functional teams, key opinion leaders (KOLs), and stakeholders to ensure the successful implementation of asset level medical affairs strategies and tactics, ultimately driving the development and commercialization of treatments in the CNS space. The position consists of both US and Global Medical TA and asset level strategies and plans.

Key Responsibilities:

•
Align to the therapeutic strategy, support the strategic vision for the respective